1. Home
  2. BXBL vs CERT Comparison

BXBL vs CERT Comparison

Compare BXBL & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BOXABL Inc. Common stock

BXBL

BOXABL Inc. Common stock

N/A

Current Price

$1.73

Market Cap

1.4B

ML Signal

N/A

Logo Certara Inc.

CERT

Certara Inc.

N/A

Current Price

$11.65

Market Cap

1.4B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
BXBL
CERT
Founded
2017
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Retail: Computer Software & Peripheral Equipment
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
BXBL
CERT
Price
$1.73
$11.65
Analyst Decision
Buy
Analyst Count
0
13
Target Price
N/A
★ $12.68
AVG Volume (30 Days)
135.1K
★ 2.6M
Earning Date
11-19-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 87.50
EPS
★ N/A
N/A
Revenue
N/A
★ $418,838,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.64
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 8.75
52 Week Low
$1.76
$4.45
52 Week High
$5.42
$12.61

Technical Indicators

Market Signals
Indicator
BXBL
CERT
Relative Strength Index (RSI) 22.17 62.32
Support Level N/A $6.26
Resistance Level $4.60 $11.73
Average True Range (ATR) 0.26 0.65
MACD -0.00 -0.00
Stochastic Oscillator 1.71 57.47

Price Performance

Historical Comparison
BXBL
CERT

About BXBL BOXABL Inc. Common stock

BOXABL Inc is engaged in building construction using modern manufacturing processes to create residential and commercial buildings that can be completed in less time and at lower cost than traditional construction. The Company has developed a building system using manufacturing processes and existing technologies and processes developed by the automotive industry. Its products include the Casita and other building solutions using patented folding and shipping technology to transport buildings on existing roadways across large geographic areas.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Share on Social Networks: